Search Results - "Bejar R"

Computationally efficient ontology selection in software requirement planning.

Authors: Brown, R. Beydoun, G. Low, G. et al.

Source: Information Systems Frontiers; Apr2016, Vol. 18 Issue 2, p349-358, 10p, 1 Color Photograph, 2 Diagrams, 2 Charts

NRAS mutations with low allele burden have independent prognostic significance for patients with lower risk myelodysplastic syndromes.

Authors: Murphy, D M Bejar, R Stevenson, K et al.

Source: Leukemia (08876924). Oct2013, Vol. 27 Issue 10, p2077-2081. 5p.

This result is not displayed to guests.
Login for full access.

P029 - Topic: AS03-Health Economics & Outcome Research/AS03a-Cost of care: ARE WE READY TO PERFORM NGS FOR ALL MDS PATIENTS ?

Authors: Santini, V. Bejar, R. Belli, C. et al.

Source: Leukemia Research. 2023 Supplement, Vol. 128, pN.PAG-N.PAG. 1p.

MENTAL RETARDATION, UNUSUAL FACIAL APPEARANCE, AND ABNORMALITIES OF THE GREAT VESSELS (NORMOCALCAEMIC STAGE OF IDIOPATHIC INFANTILE HYPERCALCAEMIA).

Authors: Bejar, R. Shear, Carol s. Schindeler, Joan et al.

Source: Journal of Mental Deficiency Research. Mar1970, Vol. 14 Issue 1, p16-24. 9p.

Subject Terms: *Intellectual disabilities, *Developmental disabilities, Hypercalcemia, Water-electrolyte imbalances, Calcium metabolism, Heart diseases

2 MOLECULAR DIAGNOSTICS.

Authors: Bejar, R.

Source: Leukemia Research. Apr2015 Supplement 1, Vol. 39, pS1-S1. 1p.

P-103 Occult NRAS mutations with very low allele burden have independent prognostic significance in lower-risk myelodysplastic syndromes.

Authors: Bejar, R. Murphy, D.M. Stevenson, K. et al.

Source: Leukemia Research. May2013 Supplement, Vol. 37, pS68-S69. 0p.

O-024 Next-generation sequencing of 213 MDS patient samples identifies mutation profiles associated with response to hypomethylating agents and overall survival.

Authors: Bejar, R. Stevenson, K. Stojanov, P. et al.

Source: Leukemia Research. May2013 Supplement, Vol. 37, pS19-S20. 0p.

288 Point mutations in myelodysplastic syndromes: Associations with clinical features and independent predictors of overall survival

Authors: Bejar, R. Stevenson, K. Abdel-Wahab, O. et al.

Source: Leukemia Research. Jan2011 Supplement 1, Vol. 35, pS113-S113. 1p.

Toll-like receptor alterations in myelodysplastic syndrome.

Authors: Wei, Y Dimicoli, S Bueso-Ramos, C et al.

Source: Leukemia (08876924). Sep2013, Vol. 27 Issue 9, p1832-1840. 9p. 6 Graphs.

249 CONNECT MDS AND AML: THE MYELODYSPLASTIC SYNDROMES (MDS) AND ACUTE MYELOID LEUKEMIA (AML) DISEASE REGISTRY.

Authors: Steensma, D. Abedi, M. Bejar, R. et al.

Source: Leukemia Research. Apr2015 Supplement 1, Vol. 39, pS124-S124. 1p.

854P Final results of a phase II study of tipifarnib in chronic myelomonocytic leukemia (CMML) and other myelodysplastic/myeloproliferative neoplasms (MDS/MPN).

Authors: Patnaik, M.M. Sekeres, M.A. DeZern, A. et al.

Source: Annals of Oncology. 2021 Supplement 5, Vol. 32, pS783-S784. 2p.

Placement of umbilical venous catheters with use of bedside real-time ultrasonography.

Authors: Greenberg, M Movahed, H Peterson, B et al.

Source: Journal of Pediatrics. 1995 Apr, Vol. 126 Issue 4, p633-635. 3p.

Real-world, multi-omics validation of the clinical relevance of molecular taxonomy for myelodysplastic syndromes (MDS).

Authors: Maggioni G Todisco G Sauta E et al.

Corporate Authors: Maggioni G Todisco G Sauta E et al.

Source: HemaSphere [Hemasphere] 2026 Jun 22; Vol. 10 (6), pp. e70406. Date of Electronic Publication: 2026 Jun 22 (Print Publication: 2026).

Publication Type: Journal Article

Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 101740619 Publication Model: eCollection Cited Medium: Internet ISSN: 2572-9241 (Electronic) Linking ISSN: 25729241 NLM ISO Abbreviation: Hemasphere Subsets: PubMed not MEDLINE

Molecular-Based Ecosystem to Improve Personalized Medicine in Chronic Myelomonocytic Leukemia.

Authors: Lanino L Hunter AM Gagelmann N et al.

Corporate Authors: Lanino L Hunter AM Gagelmann N et al.

Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2026 Jun 10; Vol. 44 (17), pp. 1608-1623. Date of Electronic Publication: 2026 Mar 27.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

Clinical, Genetic, and Pathologic Variability in Myelodysplastic Syndromes and Precursor Conditions Across Race, Ethnicity, and Sex.

Authors: Gillis N Colin-Leitzinger C Tang YH et al.

Source: American journal of hematology [Am J Hematol] 2026 Jun; Vol. 101 (6), pp. 1407-1420. Date of Electronic Publication: 2026 Mar 29.

Publication Type: Journal Article

Journal Info: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE

Exposure to Agent Orange and association with myelodysplastic syndromes.

Authors: Sekeres MA DeZern AE Otterstatter M et al.

Source: Blood advances [Blood Adv] 2026 May 12; Vol. 10 (9), pp. 3054-3058.

Publication Type: Journal Article

Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE; In Process

A novel approach to defining progression in MDS and precursor myeloid conditions in the MDS Natural History Study.

Authors: DeZern AE Gillis N Otterstatter M et al.

Source: Blood advances [Blood Adv] 2026 Apr 28; Vol. 10 (8), pp. 2743-2753.

Publication Type: Journal Article

Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

From Admission to Discharge: Leveraging NLP for Upstream Primary Coding with SNOMED CT.

Authors: Asensio Blasco E Borrat Frigola X Pastor Duran X et al.

Source: Journal of medical systems [J Med Syst] 2025 May 22; Vol. 49 (1), pp. 68. Date of Electronic Publication: 2025 May 22.

Publication Type: Journal Article

Journal Info: Publisher: Kluwer Academic/Plenum Publishers Country of Publication: United States NLM ID: 7806056 Publication Model: Electronic Cited Medium: Internet ISSN: 1573-689X (Electronic) Linking ISSN: 01485598 NLM ISO Abbreviation: J Med Syst Subsets: MEDLINE

Droplet Hi-C enables scalable, single-cell profiling of chromatin architecture in heterogeneous tissues.

Authors: Chang L Xie Y Taylor B et al.

Source: Nature biotechnology [Nat Biotechnol] 2025 Oct; Vol. 43 (10), pp. 1694-1707. Date of Electronic Publication: 2024 Oct 18.

Publication Type: Journal Article

Journal Info: Publisher: Nature America Publishing Country of Publication: United States NLM ID: 9604648 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-1696 (Electronic) Linking ISSN: 10870156 NLM ISO Abbreviation: Nat Biotechnol Subsets: MEDLINE